Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials

por Muñoz-Villegas, Patricia, Navarro-Sánchez, Andrea A, Sánchez-Ríos, Alejandra, Olvera-Montaño, Oscar, Baiza-Durán, Leopoldo M
Publicado 2021

Safety and tolerability evaluation after repeated intravitreal injections of a humanized anti-VEGF-A monoclonal antibody (PRO-169) versus ranibizumab in New Zealand white rabbits

por Baiza-Durán, Leopoldo, Sánchez-Ríos, Alejandra, González-Barón, Joel, Olvera-Montaño, Oscar, Correa-Gallegos, Elba, Navarro-Sánchez, Andrea, Muñoz-Villegas, Patricia
Publicado 2020

Validation of a preclinical dry eye model in New Zealand white rabbits during and following topical instillation of 1% ophthalmic atropine sulfate

por Sánchez‐Ríos, Alejandra, Correa‐Gallegos, Elba Yadira, Medina‐Espinoza, José Manuel, Navarro‐Sanchez, Andrea Anaid, Olvera‐Montaño, Oscar, Baiza‐Durán, Leopoldo, Muñoz‐Villegas, Patricia
Publicado 2022